Patents by Inventor Marc B. Taub
Marc B. Taub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250144296Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.Type: ApplicationFiled: January 13, 2025Publication date: May 8, 2025Applicant: ABBOTT DIABETES CARE INC.Inventors: Mark Sloan, Marc B. Taub, Gary A. Hayter, Wesley Scott Harper, Erwin S. Budiman, Charles Wei
-
Publication number: 20250140378Abstract: A system for predicting and/or managing physiological responses is configurable to (i) access one or more images depicting one or more consumables able to influence a physiological condition of a user, the one or more images being associated with one or more timepoints; (ii) access user state information associated with the user; (iii) determine a predicted physiological response to consumption of the one or more consumables by the user based on at least the one or more images and the user state information; and (iv) present an output based on the predicted physiological response to the user via a user interface.Type: ApplicationFiled: October 29, 2024Publication date: May 1, 2025Inventors: Erwin S. Budiman, Louis G. Pace, Vivek S. Rao, Peter G. Robinson, Marc B. Taub, Peter M. Voit, Chung-Che Wang, Leilani Lin Berchesi, Shridhara Alva Karinka, Jacob Sunol Canadas
-
Patent number: 12285251Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.Type: GrantFiled: December 6, 2021Date of Patent: April 29, 2025Assignee: ABBOTT DIABETES CARE INC.Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Khan
-
Patent number: 12285252Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.Type: GrantFiled: September 22, 2022Date of Patent: April 29, 2025Assignee: ABBOTT DIABETES CARE INC.Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Khan
-
Patent number: 12279867Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.Type: GrantFiled: August 15, 2023Date of Patent: April 22, 2025Assignee: ABBOTT DIABETES CARE INC.Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Khan
-
Patent number: 12220558Abstract: Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.Type: GrantFiled: January 3, 2022Date of Patent: February 11, 2025Assignee: ABBOTT DIABETES CARE INC.Inventors: Mark Sloan, Marc B. Taub, Charles Wei
-
Publication number: 20240358284Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.Type: ApplicationFiled: July 5, 2024Publication date: October 31, 2024Inventors: Marc B. TAUB, Nathan C. CROUTHER, Jai KARAN
-
Publication number: 20240358919Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.Type: ApplicationFiled: July 5, 2024Publication date: October 31, 2024Inventors: Erwin S. BUDIMAN, Gary A. HAYTER, Nathan C. CROUTHER, Marc B. TAUB, Wesley Scott HARPER, Charles WEI
-
Publication number: 20240350727Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surf ace of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.Type: ApplicationFiled: November 30, 2023Publication date: October 24, 2024Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
-
Patent number: 12121350Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.Type: GrantFiled: March 20, 2020Date of Patent: October 22, 2024Assignee: Abbott Diabetes Care Inc.Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
-
Publication number: 20240206772Abstract: An analyte monitoring system and method for an on-body sensor control device may have a capability for sensing two or more analytes of a patient includes a processor and memory with instructions for determining various machine states and outputs based on time-correlated sensor data for each of the analytes. The states and outputs may include: an alert condition for one or more analytes; an advisory message; a correction to an analyte state estimate; an indication of a malfunction of the sensor control device, a malfunction of an insulin delivery device, a medication dose calculation; or an analytical report. Examples of the system and method for dual analytes comprising glucose and ketone are described. Data may be transmitted from the sensor control device to a reader device for output to a user.Type: ApplicationFiled: December 21, 2023Publication date: June 27, 2024Inventors: Gary A. Hayter, Erwin S. Budiman, Marc B. Taub, Wesley Scott Harper
-
Patent number: 11872370Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.Type: GrantFiled: February 14, 2023Date of Patent: January 16, 2024Assignee: ABBOTT DIABETES CARE INC.Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
-
Publication number: 20240000348Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.Type: ApplicationFiled: September 18, 2023Publication date: January 4, 2024Applicant: Abbott Diabetes Care Inc.Inventors: Marc B. TAUB, Nathan C. CROUTHER, Jai KARAN
-
Publication number: 20230389838Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.Type: ApplicationFiled: August 15, 2023Publication date: December 7, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Khan
-
Patent number: 11793427Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.Type: GrantFiled: March 20, 2020Date of Patent: October 24, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Marc B. Taub, Nathan C. Crouther, Jai Karan
-
Patent number: 11793936Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.Type: GrantFiled: May 23, 2022Date of Patent: October 24, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
-
Publication number: 20230255515Abstract: Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.Type: ApplicationFiled: April 24, 2023Publication date: August 17, 2023Inventors: Mark K. SLOAN, Royce CHENG, Gary A. HAYTER, Marc B. TAUB, Mani GOPAL
-
Publication number: 20230191026Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.Type: ApplicationFiled: February 14, 2023Publication date: June 22, 2023Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
-
Patent number: 11633127Abstract: Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.Type: GrantFiled: November 17, 2020Date of Patent: April 25, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Mark K. Sloan, Royce Cheng, Gary A. Hayter, Marc B. Taub, Mani Gopal
-
Patent number: 11633126Abstract: Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.Type: GrantFiled: November 17, 2020Date of Patent: April 25, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Mark K. Sloan, Royce Cheng, Gary A. Hayter, Marc B. Taub, Mani Gopal